hydralazine has been researched along with flosequinan in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (33.33) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Cooling, MJ; Parkinson, R; Sim, MF; Yates, DB | 1 |
Miao, L; Morgan, JP; Perreault, CL; Travers, KE | 1 |
3 other study(ies) available for hydralazine and flosequinan
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Cardiovascular effects of the novel arteriovenous dilator agent, flosequinan in conscious dogs and cats.
Topics: Animals; Arteries; Blood Pressure; Cats; Chlorides; Dogs; Heart Rate; Hydralazine; Hypertension; Male; Potassium; Quinolines; Renin; Sodium; Vasodilator Agents | 1988 |
Mechanisms of positive inotropic action of flosequinan, hydralazine, and milrinone on mammalian myocardium.
Topics: Aequorin; Animals; Calcium Channel Blockers; Cardiotonic Agents; Carrier Proteins; Enzyme Inhibitors; Ferrets; Heart; Hydralazine; In Vitro Techniques; Male; Milrinone; Myocardial Contraction; Ouabain; Procaine; Pyridones; Quinolines; Sodium-Calcium Exchanger; Sodium-Hydrogen Exchangers; Sodium-Potassium-Exchanging ATPase; Stimulation, Chemical; Tetrodotoxin; Vasodilator Agents; Verapamil | 1997 |